Immunity Clinical Trial
Official title:
This Study Was a 8 Weeks, Randomized, Double-blind, Placebo-controlled Human Trial to Evaluate the Efficacy and Safety of Curcuma Longa Extract Mixture on Immune Enhancement
Verified date | April 2022 |
Source | Chonbuk National University Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This study was conducted to investigate the efficacy and safety of Curcuma longa extract mixture on immune enhancement
Status | Active, not recruiting |
Enrollment | 100 |
Est. completion date | May 27, 2022 |
Est. primary completion date | April 27, 2022 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 19 Years to 75 Years |
Eligibility | Inclusion Criteria: - Adult men and women over 19 and under 75 years - After fully hearing and fully understanding this clinical trials, those who agree to voluntarily decide to participate and to comply with the notice Exclusion Criteria: - If screening shows that the white blood cell(WBC) is less than 3000/? or more than 8000/? - Those who received influenza vaccination within 2 months before first intake of intervention - Those who have a body mass index(BMI) of less than 18.5 kg / m^2 or greater than 35 kg / m^2 at the screening - Those who have a clinically significant acute or chronic cardiovascular system, endocrine system, immune system, respiratory system, liver biliary system, kidney and urinary system, neuropsychiatry, musculoskeletal system, inflammatory and hematologic and gastrointestinal disorders - Those who take a medication or health function food that affects your promotion of immunity within 1 month prior to the screening - Those who have received antipsychotic medication within 3 months before screening - Those who alcoholic or drug abuse suspected - Those who participated in other clinical trials within 3 months before screening - Laboratory test by show the following results - Aspartate Transaminase(AST), Alanine Transaminase(ALT) > Reference range 3 times upper limit - Serum Creatinine > 2.0 mg/dL - Pregnancy or breast feeding - Those who doesn't accept the implementation of appropriate contraception of a childbearing woman - Principal Investigator judged inappropriate for participation in study because of Laboratory test result, etc. |
Country | Name | City | State |
---|---|---|---|
Korea, Republic of | Clinical Trial Center for Functional Foods Chonbuk National University Hospital | Jeonju | Jeollabuk-do |
Lead Sponsor | Collaborator |
---|---|
Chonbuk National University Hospital |
Korea, Republic of,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Changes of Natural Killer cell activity | Natural Killer cell activity was measured in study baseline and 8 week, using A ratio of effector cell to target cell ratio of 2.5:1, 5:1, 10:1.
Natural Killer cell activity(%) = (Experimental - Effector Spontaneous - Target Spontaneous) / (Target Maximum - Target Spontaneous) × 100 |
baseline and 8 weeks | |
Secondary | Changes of Interleukin-2, Interleukin-12, Interferon-Gamma and Tumor necrosis factor-alpha | For blood Interleukin-2(pg/mL), Interleukin-12(pg/mL), Interferon-Gamma(pg/mL) and Tumor necrosis factor-alpha(pg/mL) analysis, collect 3 ml of blood in one serum separate tube for 5 ml, leave at room temperature for 30 minutes for clotting, after then centrifuge at 3000 rpm (or 2000 xg) for 10 minutes. | baseline and 8 weeks | |
Secondary | Changes of Wisconsin Upper Respiratory Symptom Survey-21(WURSS-21) | The Wisconsin Upper Respiratory Symptom Survey-21 will investigate on the day of visit (1st, 2nd and 3rd visits).
The Wisconsin Upper Respiratory Symptom Survey-21 consists of seven stages, including individual symptoms, functional quality of life, and overall improvement. Find the total score of symptoms by obtaining the sum of symptom questions, and the total score of quality of life by obtaining the sum of life questions. Additionally, the sum of the total points of symptoms and quality of life is obtained. All items of symptom score rank on a seven-point scale(1=very mild and 7=severe), where a higher score means higher severity. The symptom score ranges from 0(Do not have this symptom) to 70. All items of quality of life score rank on a seven-point scale(1=very mildly and 7=severely), where a higher score means higher severity. The quality of life score ranges from 0(Not at all) to 63. Therefore, the total score ranges from 0 to 133. |
baseline, 4 weeks and 8 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02814617 -
The Efficacy and Safety of Cordyceps Sinensis Mycelium Culture Extract(Paecilomyces Hepiali, CBG-CS-2) on Promotion of Immunity
|
Phase 2/Phase 3 | |
Completed |
NCT02244372 -
Efficacy and Safety of Cordyceps Sinensis Mycelium Culture Extract(Paecilomyces Hepiali, CBG-CS-2) on Promotion of Immunity
|
N/A | |
Completed |
NCT00990002 -
Investigation of A Children's Beverage Containing Different Probiotics
|
N/A | |
Completed |
NCT00788021 -
Protective Immunity Project 01
|
N/A | |
Completed |
NCT01736787 -
Efficacy and Safety of Cauliflower Mushroom Extract on Promotion of Immunity
|
N/A | |
Recruiting |
NCT04579588 -
Understanding Immunity to the Flu Vaccine in COVID-19 Patients
|
||
Completed |
NCT04798677 -
Efficacy and Tolerability of ABBC1 in Volunteers Receiving the Influenza or Covid-19 Vaccine
|
N/A | |
Completed |
NCT05162820 -
Impact of Solarplast® on Immunity in Active Smokers and Non-smokers
|
N/A | |
Completed |
NCT01657656 -
Vitamin D Supplementations as Adjunct to Anti-Tuberculosis Drugs in Mongolia
|
N/A | |
Completed |
NCT05585021 -
Clinical Study on the Effect of Probiotic Compound Powder on the Immunity Improvement of Preschool Children
|
N/A | |
Recruiting |
NCT05117385 -
The Effect of the Consumption of 4 Botanical Extracts on Immunity in Healthy Adults (B-4-Immune)
|
N/A | |
Completed |
NCT05190237 -
the Efficacy and Safety of Fermented Soybean(Doenjang Powder) on Intestinal Microflora and Immune Enhancement.
|
N/A | |
Completed |
NCT04647071 -
Allium Extracts on the Incidence of Respiratory Infection Symptoms in Healthy Elderly Volunteers
|
N/A | |
Completed |
NCT04031222 -
Mechanisms of Inflammation, Immunity, Islet Cell and Intestinal Hormone Changes in Youth at Risk for Diabetes
|
||
Completed |
NCT04010331 -
Efficacy and Safety of Nokyong Mixture Extract(CME-PI) on Promotion of Immunity
|
N/A | |
Completed |
NCT03067714 -
A Clinical Study to Investigate the Effect of a Partially Hydrolysed Infant Formula With Added Synbiotics on Gut Microbiota Composition and Clinical Effectiveness in Infants at High Risk of Developing Allergy
|
Phase 3 | |
Completed |
NCT04664309 -
Understanding Immunity to the COVID-19 Vaccines
|
||
Withdrawn |
NCT06121362 -
Effect of Protocatechuic Acid on Biochemical Markers of Immunity Status in Healthy Adults
|
N/A | |
Recruiting |
NCT02166931 -
BRAND'S® Essence of Chicken in the Promotion of Resilience and Resistance to Stress-associated Cognitive Inhibition
|
N/A | |
Recruiting |
NCT00645996 -
The Influence of Probiotics on the Immunologic Response to Vaccinations in Infants
|
N/A |